share_log

CASI Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James Huang(18.0%),Panacea Venture Healthcare Fund II, L.P.(17.4%), etc.

SEC announcement ·  Nov 10, 2023 05:13
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.